United States

Cardinal Health Inc (CAH)

CAH on New York Consolidated

26 Jul 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Cardinal Health reports 5.8 pct passive stake in Navidea Biopharma
Monday, 13 Mar 2017 04:03pm EDT 

Cardinal Health Inc :Cardinal Health, Inc reports 5.8 percent passive stake in navidea biopharmaceuticals inc as of March 3, 2017 - sec filing.  Full Article

Navidea enters into letter of intent with cardinal health for sale of Lymphoseek in North America
Tuesday, 6 Sep 2016 06:59am EDT 

Navidea Biopharmaceuticals Inc: Navidea Biopharmaceuticals enters into letter of intent with cardinal health for the sale of Lymphoseek® in North America . Total consideration to Navidea would be capped at $310 million. . Navidea retains rights to non-competitive diagnostic indications and all therapeutic applications .Navidea would receive $80 million at closing, with future consideration tied to annual sales of Lymphoseek, certain milestones.  Full Article

Medical Developments International signs respiratory deal with Cardinal Health Inc
Tuesday, 9 Aug 2016 12:43am EDT 

Medical Developments International Ltd : MVP signs respiratory deal in the United States . Agreed a distribution deal with Cardinal Health Inc for distribution of "space chamber" anti-static respiratory devices in the US .  Full Article

Cardinal Health Q4 non-gaap earnings per share $1.14
Tuesday, 2 Aug 2016 07:00am EDT 

Cardinal Health Inc : Cardinal Health reports Q4 and fiscal 2016 results, provides fiscal 2017 outlook . Q4 non-gaap earnings per share $1.14 . Sees FY 2017 non-GAAP earnings per share $5.48 to $5.73 from continuing operations . Q4 GAAP earnings per share $1.02 from continuing operations . Q4 revenue $31.4 billion . Q4 earnings per share view $1.13, revenue view $31.19 billion -- Thomson Reuters I/B/E/S . Fy2017 earnings per share view $5.70 -- Thomson Reuters I/B/E/S .Expects a year-over-year decline in its non-gaap earnings per share for Q1 2017 in high-single- to low-double-digit-percent range.  Full Article

Cardinal Health enters into amended and restated 5-yr credit agreement
Tuesday, 21 Jun 2016 10:53am EDT 

Cardinal Health Inc : On June 16, 2016, co entered into an amended and restated five-year credit agreement - SEC Filing . Amended and restated credit agreement extends term of revolving credit facility to June 16, 2021 - SEC Filing . Says effective on June 30, 2016, will reduce its committed receivables sales facility program from $950 million to $700 million . Amended and restated credit agreement increases revolving credit available to company to $1.75 billion Source - http://1.usa.gov/28MtX3s Further company coverage: [CAH.N] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Cardinal Health to prepare NETSPOT doses for Advanced Accelerator Applications
Thursday, 9 Jun 2016 07:51am EDT 

:Advanced Accelerator Applications S.A. says selected Cardinal Health to supply Gallium 68 dotatate doses to u.s. Hospitals and imaging centers.  Full Article

Biosensors announces strategic agreement with Cardinal Health
Thursday, 12 May 2016 10:06am EDT 

Biosensors International Group Ltd : Has entered into a strategic distribution agreement with Cardinal Health . Under agreement, cardinal health's interventional vascular business to sell biosensors family of des in european countries . Under agreement, cardinal health's interventional vascular business to sell co's family of des in Australia, New Zealand .Biosensors announces strategic agreement with cardinal health.  Full Article

Cardinal Health Inc board of directors approves quarterly dividend
Tuesday, 2 Feb 2016 04:05pm EST 

Cardinal Health Inc:Board of directors approved a quarterly dividend of $0.387 per share.Quarterly dividend will be payable on April 15 to shareholders of record as on April 1.  Full Article

Cardinal Health Inc reaffirms FY 2016 EPS guidance
Tuesday, 12 Jan 2016 07:31am EST 

Cardinal Health Inc:Reaffirms FY 2016 non-GAAP diluted earnings per share (EPS) guidance of $5.15 to $5.35, representing an 18 to 22 percent growth rate compared to FY 2015.  Full Article

Cardinal Health announces quarterly dividend
Wednesday, 4 Nov 2015 04:30pm EST 

Cardinal Health Inc:Approved a regular quarterly dividend of $0.3870 per share, payable Jan. 15, 2016, to shareholders of record on Jan. 4, 2016.  Full Article

Cardinal Health to pay $2.72 million in false claims settlement

Cardinal Health Inc has agreed to pay nearly $2.72 million to resolve claims a company it later acquired engaged in a scheme to defraud Medicare through its marketing of negative pressure wound treatment devices, the U.S. Justice Department said.